Press release
Non-Alcoholic Steatohepatitis Biomarkers Market Briefing 2023 to 2030 | , Allergan, AstraZeneca
The non-alcoholic steatohepatitis (NASH) biomarkers market refers to the market for diagnostic tests and biomarkers used in the detection and monitoring of non-alcoholic steatohepatitis, a severe form of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by the presence of inflammation and liver cell damage, which can progress to advanced fibrosis, cirrhosis, and liver cancer.
The non-alcoholic steatohepatitis (NASH) biomarker market is estimated to exhibit growth at a CAGR of 20.9% during the years 2023-2030.
Get a Sample PDF of the report: https://www.infinitybusinessinsights.com/request_sample.php?id=1039415&mode=VG96
Competition Dashboard: , Allergan, AstraZeneca, Bristol Myers Squibb Company, Echosens SA , Genfit SA, Gilead Sciences Inc, Madrigal Pharmaceuticals, Medpace, Merck & Co, Novartis AG, Novo Nordisk, Pfizer Inc, ProSciento+ NORDIC BIOSCIENCE, Siemens Healthcare GmbH, Viking Therapeutics, ZydusCadila, amongst others., and others.
Overview:
Non-alcoholic fatty liver disease (NAFLD) has become a global health concern due to the rising prevalence of obesity, sedentary lifestyles, and unhealthy dietary habits. NASH, a subset of NAFLD, is particularly concerning as it can lead to serious complications. Early and accurate diagnosis of NASH is crucial for timely intervention and treatment.
Segment Assessment
The segment is observed to remain highly attractive over the approaching years. The rise in demand for Non-Alcoholic Steatohepatitis Biomarkers due to its effective microelectronics component can favor rise of the market in the near future. The Non-Alcoholic Steatohepatitis Biomarkers segment can gain a healthy momentum through the review period till 2030.
Enquire For Discount: https://www.infinitybusinessinsights.com/ask_for_discount.php?id=1039415&mode=VG96
Non-Alcoholic Steatohepatitis Biomarkers Market segment by Type:
• Biomarker Panels
• Fibrosis Biomarkers
• Imaging Biomarkers
• Others
Non-Alcoholic Steatohepatitis Biomarkers Market segment by Application:
• Hospitals
• Diagnostic Centers
• Others
Ask for a Sample Report: https://www.infinitybusinessinsights.com/request_sample.php?id=1039415&mode=VG96
Geographic Segment Covered in the Non-Alcoholic Steatohepatitis Biomarkers Market Report:
The report has been segmented into following regions and countries-
North America has been a key market for NASH biomarkers due to the high prevalence of non-alcoholic fatty liver disease (NAFLD) and NASH in the region. The United States, in particular, has witnessed a significant rise in NASH cases, leading to increased demand for diagnostic biomarkers. Additionally, favorable reimbursement policies, robust healthcare infrastructure, and ongoing research and development activities contribute to the growth of the NASH biomarkers market in North America.
Europe is another significant market for NASH biomarkers. Countries like Germany, France, and the United Kingdom have witnessed a rise in the prevalence of NAFLD and NASH, primarily due to lifestyle changes and increasing obesity rates. The presence of well-established healthcare systems, increased awareness about liver diseases, and a growing focus on early diagnosis and intervention drive the demand for NASH biomarkers in the European market.
The Asia Pacific region is expected to witness substantial growth in the NASH biomarkers market. Rapid urbanization, sedentary lifestyles, and changes in dietary habits have led to an increasing burden of NAFLD and NASH in countries like China, India, and Japan. Rising healthcare expenditure, increasing awareness about liver diseases, and the availability of advanced diagnostic technologies are driving the market growth in this region.
Trends:
Increasing Prevalence: The prevalence of NASH is on the rise globally, driven by the growing obesity epidemic and the prevalence of metabolic risk factors such as type 2 diabetes and dyslipidemia. This trend is fueling the demand for NASH biomarkers.
Therapeutic Development: The lack of approved pharmacological treatments for NASH has prompted increased efforts in drug development. Biomarkers play a crucial role in clinical trials by enabling the assessment of treatment efficacy and patient stratification. The demand for biomarkers in NASH clinical trials is expected to increase with the advancement of therapeutic options.
Focusing your research energy on these areas will equip you with a solid base for smart marketing decisions
Table of contents:
1 Study Coverage
1.1 Non-Alcoholic Steatohepatitis Biomarkers Product Introduction
1.2 Market by Type
1.3 Market by Application
1.4 Study Objectives
1.5 Years Considered
2 Global Non-Alcoholic Steatohepatitis Biomarkers Production
2.1 Global Production Capacity (2023-2030)
2.2 Global Production by Region: 2023 VS 2030
2.3 Global Non-Alcoholic Steatohepatitis Biomarkers Production by Region
3 Global Non-Alcoholic Steatohepatitis Biomarkers Sales in Volume and Value Estimates and Forecasts
3.1 Global Sales Estimates and Forecasts 2023-2030
3.2 Global Revenue Estimates and Forecasts 2023-2030
3.3 Global Revenue by Region: 2023 VS 2030
3.4 Global Sales by Region
3.5 Global Revenue by Region
Continue....
Browse Full Report: https://www.infinitybusinessinsights.com/enquiry_before_buying.php?id=1039415&discount=20&mode=VG96
Contact Us:
Amit Jain
Sales Co-Ordinator
International: +1 518 300 3575
Email: inquiry@infinitybusinessinsights.com
Website: https://www.infinitybusinessinsights.com
About Us:
Infinity Business Insights (IBI) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis Biomarkers Market Briefing 2023 to 2030 | , Allergan, AstraZeneca here
News-ID: 3117692 • Views: …
More Releases from Infinitybusinessinsights
Automotive End-Point Authentication Market Momentum analyzes an in-depth survey …
Automotive end-point authentication refers to the process of verifying the identity of users or devices accessing the endpoints in automotive systems, such as vehicles, through various authentication methods. With the increasing integration of advanced technologies, including connected car systems, autonomous driving, and in-vehicle infotainment systems, the need for robust end-point authentication solutions in the automotive industry is becoming paramount. These solutions help prevent unauthorized access, mitigate cybersecurity threats, and safeguard…
Connected Car Devices Market Revolution 2024 Vision Outlook and Innovation Spotl …
The connected car devices market has experienced substantial growth in recent years, primarily driven by advancements in automotive technology and the increasing demand for connectivity solutions in vehicles. Connected car devices encompass a wide range of technologies designed to enhance the driving experience, improve safety, provide entertainment, and enable vehicle-to-vehicle communication. These devices include infotainment systems, telematics units, connected sensors, in-car Wi-Fi hotspots, and various applications integrated into the vehicle's…
Rubber Molding for Automotive Components and Sub-Components Market Exploration D …
Rubber molding plays a crucial role in the automotive industry, providing components and sub-components essential for vehicle performance, safety, and comfort. These components include seals, gaskets, hoses, bushings, and vibration isolators, among others. Rubber molding techniques such as injection molding, compression molding, and transfer molding are utilized to manufacture these parts, ensuring durability, flexibility, and resistance to environmental factors and chemicals commonly encountered in automotive applications.
The worldwide Rubber Molding for…
Leather Seat Covers Market Resurgence 2024 Future Prediction and Pioneering Deve …
The leather seat covers market encompasses a range of products designed to enhance the aesthetic appeal, comfort, and durability of vehicle interiors. Leather seat covers are popular among vehicle owners seeking luxurious and premium upholstery options for their cars, trucks, and motorcycles. These seat covers are available in various designs, colors, and textures, catering to diverse consumer preferences. The market for leather seat covers is driven by factors such as…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
